Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Aave DAO Considers Annual $50 Million AAVE Buyback

Aave DAO Considers Annual $50 Million AAVE Buyback

PortalcriptoPortalcripto2025/10/22 18:15
By:by Editor
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Phase III trial failure for new heart drug causes Novo Nordisk shares to plunge: increasing reliance on weight-loss drugs, R&D transformation faces new test

Novo Nordisk announced on Friday that its cardiovascular drug ziltivekimab failed to reduce the risk of major cardiovascular events in a phase III clinical trial involving 6,300 patients, causing its stock price to plummet by 8.7% in a single day. The market had held high expectations for ziltivekimab, hoping the drug would establish a second growth curve beyond diabetes and weight-loss medications.

华尔街见闻2026/07/31 22:26